Guja Astrea Selected Research

Myotonic Dystrophy (Dystrophia Myotonica)

10/2016

Learning disabilities in neuromuscular disorders: a springboard for adult life.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guja Astrea Research Topics

Disease

9	Muscular Diseases (Myopathy) 02/2024 - 01/2013
4	Muscular Dystrophies (Muscular Dystrophy) 01/2018 - 03/2014
3	Disease Progression 02/2024 - 12/2021
3	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2024 - 07/2012
2	Neuromuscular Diseases (Neuromuscular Disease) 11/2022 - 06/2020
2	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 03/2019 - 01/2018
2	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 01/2018 - 10/2016
1	Cardiomyopathies (Cardiomyopathy) 01/2024
1	Minicore Myopathy with External Ophthalmoplegia 01/2022
1	Central Core Myopathy (Central Core Disease) 01/2022
1	COVID-19 12/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2019
1	Walker-Warburg Syndrome 01/2018
1	Myotonic Dystrophy (Dystrophia Myotonica) 10/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016
1	Cognitive Dysfunction 01/2016
1	Congenital myasthenic syndrome with episodic apnea 01/2016
1	Hypogonadism (Hypergonadotropic Hypogonadism) 07/2015
1	Intellectual Disability (Idiocy) 03/2014
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 03/2014
1	Group II Malformations of Cortical Development 03/2014
1	Neutral Lipid Storage Disease with Myopathy 01/2013
1	Vocal Cord Paralysis 08/2012
1	Down Syndrome (Down's Syndrome) 09/2007

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 03/2019 - 08/2012
3	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2022 - 05/2015
3	Dystroglycans (Dystroglycan)IBA 01/2018 - 01/2016
2	DystrophinIBA 01/2024 - 01/2024
2	mannose 1-phosphate guanylyltransferaseIBA 01/2018 - 01/2018
2	Guanosine Diphosphate Mannose (GDP Mannose)IBA 01/2018 - 01/2018
1	Biomarkers (Surrogate Marker)IBA 02/2024
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 01/2023
1	mesoglycanIBA 01/2023
1	CollagenIBA 11/2022
1	EnzymesIBA 01/2018
1	Muscle Proteins (Muscle Protein)IBA 10/2016
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 03/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	choline transporterIBA 01/2016
1	Cholinergic Agents (Cholinergics)IBA 01/2016
1	Growth Hormone (Somatotropin)IBA 07/2015
1	Dyneins (Dynein)IBA 03/2014
1	Creatine Kinase (Creatine Phosphokinase)IBA 03/2014
1	Cytoplasmic DyneinsIBA 03/2014
1	LipidsIBA 01/2013
1	Lipase (Acid Lipase)FDA Link 01/2013
1	OsteopontinIBA 07/2012
1	Reduced Folate Carrier ProteinIBA 09/2007
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 09/2007
1	HomocysteineIBA 09/2007
1	Folic Acid (Vitamin M)FDA LinkGeneric 09/2007

Therapy/Procedure

4	Therapeutics 02/2024 - 01/2017
1	Continuity of Patient Care 12/2021